SUZHOU BASECARE MEDICAL CORPORATION LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 HKD | -1.48% |
|
+3.09% | -14.89% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -14.89% | 68.91M | - | ||
| -16.65% | 8.34B | B+ | ||
| +39.98% | 3.59B | C+ | ||
| -32.00% | 2.75B | B- | ||
| -7.71% | 2.48B | - | ||
| -9.98% | 2.32B | B- | ||
| -13.29% | 1.79B | C- | ||
| -19.46% | 1.54B | A- | ||
| -40.57% | 1.21B | C+ | ||
| +9.70% | 1.13B | B+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 2170 Stock
- Ratings Suzhou Basecare Medical Corporation Limited
